This filing lists securities holdings reported on the form 13F filed on 08-10-2023 pursuant to a request for confidential treatment and for which confidential treatment expired on 12-01-2023.
Name | Title | City, State | Date |
---|---|---|---|
Santiago Donoso | CEO Provida | Santiago, Chile | 2/7/2024 |
This Amendment No. 3 to the Reporting Persons Form 13F for the quarter ended June 30, 2023, is being filed to correct the explanatory note included in Amendment No. 2. Such note should have read: On August 10, 2023, the Reporting Person filed its Form 13F Holdings Report for the quarter ended June 30, 2023 separately and confidentially with the U.S. Securities and Exchange Commission, under a request for confidential treatment. However, the Reporting Person did not file a public Form 13F at that time, and instead filed an initial public Form 13F Holdings Report for the quarter ended June 30, 2023 on January 9, 2024, after confidential treatment had expired. As such, the Reporting Person filed an amendment on February 5, 2024, to report what it should have publicly filed on August 10, 2023, with the positions for which it requested confidential treatment omitted, and is filing this amendment to publicly report the positions for which it requested confidential treatment. Please note that this 13F Holdings Report filer is affiliated with MetLife Investment Management, LLC and Metropolitan Life Insurance Company who also file 13F Holdings Reports. Each entity files its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. All three 13F Holdings Report filers are under common control of their ultimate parent, MetLife, Inc., who files a 13F Combination Report.
Num | Name | Location | File Number |
---|---|---|---|
1 | METLIFE INC | New York, NY | 028-18621 |